Vera Therapeutics (NASDAQ: VERA)
Vera Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Vera Therapeutics Company Info
Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.
News & Analysis
Could This Stock Be the Next Biotech Buyout?
Vertex Pharmaceuticals' $4.9 billion purchase of Alpine Immune Sciences probably won't be the last acquisition of a company focused on kidney disease.
Why Vera Therapeutics Stock Soared by 22% This Week
Executive changes and a bullish analyst take combined to boost sentiment on the company.
This Promising Small-Cap Biotech Stock Could Rise 70%, According to Wall Street
Is the stock's risk worth the potential reward?
Why Shares of Vera Therapeutics Jumped Tuesday
The stock bounced back Tuesday from a three-month low it hit on Monday.
Why Shares of Vera Therapeutics Jumped Tuesday
The company announced early phase 2 trials information regarding its lead therapy.
Why Shares of Vera Therapeutics Are Soaring Monday
The company, which specializes in autoimmune disorders affecting the kidney, benefited from a renewed interest in kidney therapies.
Why Vera Therapeutics Stock Bolted Higher This Week
Vera's stock gained a noteworthy 49% this week.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.